Difficulties in supplying methylphenidate: ANSM publishes recommendations for pharmacists

In response to global shortages of medications containing methylphenidate, the French National Agency for the Safety of Medicines and Health Products (ANSM) has updated its recommendations for pharmacists. To ensure patient continuity of treatment, ANSM allows pharmacists to prescribe alternative medications if the initial medication is unavailable. French National Agency for the Safety of Medicines and Health Products (ANSM) updates recommendations for managing methylphenidate shortages due to supply difficulties. Pharmacists can replace unavailable methylphenidate medications with alternative options.